These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36861832)

  • 1. Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models.
    Chen A; Chao Y; Zou H; McCarl LH; Kohanbash G; Hu B
    STAR Protoc; 2023 Mar; 4(1):102049. PubMed ID: 36861832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol to generate traceable CAR T cells for syngeneic mouse cancer models.
    Zhang D; Krimitza E; Han K; Su R; Xu DJ; Xu JR; Gong Y; Fan Y
    STAR Protoc; 2024 Mar; 5(1):102898. PubMed ID: 38367235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syngeneic Mouse Model of Glioblastoma: Intracranial Implantation of GL261 Cells.
    Kaminska P; Cyranowski S; Pilanc P; Malik AR
    Methods Mol Biol; 2024; 2746():135-146. PubMed ID: 38070086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal delivery of experimental compounds in orthotopic brain tumor mouse models.
    Eyme KM; Carvalho L; Badr CE
    STAR Protoc; 2021 Mar; 2(1):100290. PubMed ID: 33532737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of immune populations in the tumor microenvironment of diffuse midline glioma orthotopic mouse models by flow cytometry.
    Ausejo-Mauleon I; Labiano S; Alonso MM
    STAR Protoc; 2024 Mar; 5(1):102803. PubMed ID: 38159270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas.
    Enríquez Pérez J; Kopecky J; Visse E; Darabi A; Siesjö P
    BMC Cancer; 2020 Jan; 20(1):7. PubMed ID: 31900109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of the immune cell fraction from murine brain tumor microenvironment.
    Mastandrea I; Sher D; Magod P; Friedmann-Morvinski D
    STAR Protoc; 2022 Mar; 3(1):101106. PubMed ID: 35098162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine brain tumor microenvironment immunophenotyping using mass cytometry.
    McClellan BL; Alghamri MS; Thalla R; Lowenstein PR; Castro MG
    STAR Protoc; 2022 Jun; 3(2):101357. PubMed ID: 35634359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation of GL261 neurospheres into C57/BL6 mice: a more reliable syngeneic graft model for research on glioma-initiating cells.
    Yi L; Zhou C; Wang B; Chen T; Xu M; Xu L; Feng H
    Int J Oncol; 2013 Aug; 43(2):477-84. PubMed ID: 23708048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol to analyze antitumor immunity of orthotopic injection and spontaneous murine high-grade glioma models using flow cytometry and single-cell RNA sequencing.
    Park JH; Kim CW; Kim HJ; Kim HJ; Lee JH; Lee HK
    STAR Protoc; 2022 Sep; 3(3):101607. PubMed ID: 35990740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors.
    Oudin A; Baus V; Barthelemy V; Fabian C; Klein E; Dieterle M; Wantz M; Hau AC; Dording C; Bernard A; Michelucci A; Yabo YA; Kanli G; Keunen O; Bjerkvig R; Niclou SP; Golebiewska A
    STAR Protoc; 2021 Jun; 2(2):100534. PubMed ID: 34027491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma.
    Chuntova P; Yamamichi A; Chen T; Narayanaswamy R; Ronseaux S; Hudson C; Tron AE; Hyer ML; Montoya M; Mende AL; Nejo T; Downey KM; Diebold D; Lu M; Nicolay B; Okada H
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35606087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.
    Hardcastle J; Mills L; Malo CS; Jin F; Kurokawa C; Geekiyanage H; Schroeder M; Sarkaria J; Johnson AJ; Galanis E
    Neuro Oncol; 2017 Apr; 19(4):493-502. PubMed ID: 27663389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance.
    Liu T; Zhu C; Chen X; Guan G; Zou C; Shen S; Wu J; Wang Y; Lin Z; Chen L; Cheng P; Cheng W; Wu A
    Neuro Oncol; 2022 Jul; 24(7):1113-1125. PubMed ID: 35148413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcγRIIB phosphorylation in glioblastoma.
    Liu Y; Song C; Shen F; Zhang J; Song SW
    PLoS One; 2019; 14(9):e0222999. PubMed ID: 31560714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model.
    Murty S; Haile ST; Beinat C; Aalipour A; Alam IS; Murty T; Shaffer TM; Patel CB; Graves EE; Mackall CL; Gambhir SS
    Oncoimmunology; 2020 May; 9(1):1757360. PubMed ID: 32923113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
    Flores-Toro JA; Luo D; Gopinath A; Sarkisian MR; Campbell JJ; Charo IF; Singh R; Schall TJ; Datta M; Jain RK; Mitchell DA; Harrison JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1129-1138. PubMed ID: 31879345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.
    Saha D; Wakimoto H; Peters CW; Antoszczyk SJ; Rabkin SD; Martuza RL
    Clin Cancer Res; 2018 Jul; 24(14):3409-3422. PubMed ID: 29599413
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types.
    Khalsa JK; Cheng N; Keegan J; Chaudry A; Driver J; Bi WL; Lederer J; Shah K
    Nat Commun; 2020 Aug; 11(1):3912. PubMed ID: 32764562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody.
    Nigam S; McCarl L; Kumar R; Edinger RS; Kurland BF; Anderson CJ; Panigrahy A; Kohanbash G; Edwards WB
    Mol Imaging Biol; 2020 Jun; 22(3):685-694. PubMed ID: 31529407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.